Literature DB >> 16367872

Inhibition of mitogen-activated protein kinase signalling by Bacillus anthracis lethal toxin causes destabilization of interleukin-8 mRNA.

Sarah Batty1, Edith M C Chow, Altaf Kassam, Sandy D Der, Jeremy Mogridge.   

Abstract

Bacillus anthracis must overcome host innate immune defences to establish a systemic anthrax infection. This is facilitated in part by lethal toxin (LT), a secreted virulence factor that consists of a cell-binding moiety, protective antigen (PA), and an enzymatic moiety, lethal factor (LF). PA binds cells through protein receptors and mediates the delivery of LF to the cytosol. LF is a protease that cleaves amino-terminal fragments from mitogen-activated protein kinase kinases (MAPKKs), preventing phosphorylation of their downstream targets. Here we report that LT reduces the amount of interleukin (IL)-8 produced and secreted by human endothelial cells. The reduction of IL-8 levels by LT was not attributable to reduced expression from the IL-8 promoter, but resulted from destabilization of IL-8 mRNA. Destabilization by LT was mediated through the 3' untranslated region of the IL-8 transcript and could be mimicked by pharmacological inhibitors of MAPK pathways. LT diminished the induction of IL-8 mRNA and protein by lipopolysaccharide, indicating that the toxin can impair the ability of these cells to initiate an immune response. Destabilization of a cytokine transcript represents a new interference strategy used by either a bacterial or viral pathogen to reduce cytokine expression and may help B. anthracis to evade host immune defences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16367872     DOI: 10.1111/j.1462-5822.2005.00606.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  21 in total

1.  The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen.

Authors:  Mandy Y Go; Edith M C Chow; Jeremy Mogridge
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

2.  Acquired coagulant factor VIII deficiency induced by Bacillus anthracis lethal toxin in mice.

Authors:  Der-Shan Sun; Po-Chien Lee; Jyh-Hwa Kau; Yung-Luen Shih; Hsin-Hsien Huang; Chen-Ru Li; Chin-Cheng Lee; Yu-Ping Wu; Kuo-Ching Chen; Hsin-Hou Chang
Journal:  Virulence       Date:  2015-04-23       Impact factor: 5.882

3.  Inhibition of interleukin-8 production in human endothelial cells by Staphylococcus aureus supernatant.

Authors:  A Tajima; K Seki; H Shinji; S Masuda
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

4.  Anthrax lethal toxin promotes dephosphorylation of TTP and formation of processing bodies.

Authors:  Edith M C Chow; Sarah Batty; Jeremy Mogridge
Journal:  Cell Microbiol       Date:  2009-12-08       Impact factor: 3.715

5.  Anthrax lethal toxin enhances IkappaB kinase activation and differentially regulates pro-inflammatory genes in human endothelium.

Authors:  Jason M Warfel; Felice D'Agnillo
Journal:  J Biol Chem       Date:  2009-07-20       Impact factor: 5.157

6.  Bacillus anthracis lethal toxin represses MMTV promoter activity through transcription factors.

Authors:  Zhigang Kang; Jeanette I Webster Marketon; Antoinette Johnson; Esther M Sternberg
Journal:  J Mol Biol       Date:  2009-04-21       Impact factor: 5.469

Review 7.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

8.  Toxin inhibition of antimicrobial factors induced by Bacillus anthracis peptidoglycan in human blood.

Authors:  Soumitra Barua; Janaki K Iyer; Jason L Larabee; Brent Raisley; Molly A Hughes; K Mark Coggeshall; Jimmy D Ballard
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

Review 9.  Cellular and systemic effects of anthrax lethal toxin and edema toxin.

Authors:  Mahtab Moayeri; Stephen H Leppla
Journal:  Mol Aspects Med       Date:  2009-07-26

10.  Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature.

Authors:  Shihui Liu; Hailun Wang; Brooke M Currie; Alfredo Molinolo; Howard J Leung; Mahtab Moayeri; John R Basile; Randall W Alfano; J Silvio Gutkind; Arthur E Frankel; Thomas H Bugge; Stephen H Leppla
Journal:  J Biol Chem       Date:  2007-11-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.